Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects-Reference-Cited by-同舟云学术

Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects

Published:2003-09-30 Issue:2 Volume:57 Page:181-187
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Kyrklund Carl,Backman Janne T.,Neuvonen Mikko,Neuvonen Pertti J.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference32 articles.

1. Niemi M Backman JT Fromm MF Neuvonen PJ Kivistö KT. Clin Pharmacokinet 2003 42 819 850

2. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes;Kolars;J Clin Invest,1992

3. Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily;Combalbert;Drug Metab Dispos,1989

4. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin;Greiner;J Clin Invest,1999

5. The effect of rifampin treatment on intestinal expression of human MRP transporters;Fromm;Am J Pathol,2000

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic OATP1B zonal distribution: Implications for rifampicin‐mediated drug–drug interactions explored within a PBPK framework;CPT: Pharmacometrics & Systems Pharmacology;2024-06-19

2. The Effect of Inflammatory Bowel Disease and Irritable Bowel Syndrome on Pravastatin Oral Bioavailability: In vivo and in silico evaluation using bottom-up wbPBPK modeling;AAPS PharmSciTech;2024-04-11

3. Microfluidic technology and simulation models in studying pharmacokinetics during pregnancy;Frontiers in Pharmacology;2023-08-17

4. An Assessment of Occasional Bio-Inequivalence for BCS1 and BCS3 Drugs: What are the Underlying Reasons?;Journal of Pharmaceutical Sciences;2022-01

5. Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interaction Potential of Vemurafenib Using R-Value and Physiologically-Based Pharmacokinetic Models;Journal of Pharmaceutical Sciences;2021-01